Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Jay R. Lieberman, MD

    TitleChair and Professor of Orthopaedic Surgery
    SchoolKeck School of Medicine of USC
    DepartmentOrthopaedic Surgery
    AddressHCT 1520 San Pablo Street
    Health Sciences Campus
    Los Angeles California 90033
    Phone+1 323 442 8117
      Other Positions
      TitleChief of Orthopaedic Surgery Service, Keck Medical Center


       Overview 
       Overview
      Dr. Lieberman is professor and chair of the Department of Orthopaedic Surgery at the Keck School of Medicine of USC and director of the Institute of Orthopaedics at the Keck Medical Center of USC. He is also the President of USC Care. Dr. Lieberman is internationally recognized for his expertise in primary and revision total hip and knee replacement and treatment of osteonecrosis (bone death) of the hip and knee. He is interested in improving outcomes after total hip and knee replacement, the use of pain protocols and aggressive PT to speed recovery after surgery and preventing blood clots after total joint replacement surgery. Dr. Lieberman is also studying the influence of spirituality on the results of total joint replacement.

      Named one of the Outstanding Total Hip and Knee Orthopaedic Surgeons by Becker’s Orthopaedic and Spine Review, Dr. Lieberman has also been named to the Best Doctors in America list and Super Doctors of Southern California. A member of the Hip Society, Knee Society and International Hip Society, Dr. Lieberman also serves on the Board of Directors of the American Association of Hip and Knee Surgeons (AAHKS) and he was President of AAHKS from 2015-2016. He has co-edited two books for the American Academy of Orthopaedic Surgeons on surgical techniques related to total hip and knee arthroplasty. He co-edited the textbook Surgery of the Hip and he was the inaugural editor of the highly popular review text AAOS Comprehensive Orthopaedic Review. He has published more than 200 manuscripts, book chapters, reviews and abstracts.

      Dr. Lieberman has won numerous awards including the Frank Stinchfield Hip Society Award; the Marshall Urist Award in recognition of his contribution to the field of tissue engineering; and the prestigious Elizabeth Winston Lanier Award for his pioneering work related to the development of regional gene therapy to enhance bone repair. Dr. Lieberman received his medical degree from the Albany Medical College of Union University and completed his fellowship training in total joint replacement at the Hospital for Special Surgery in New York.


       Biography 
       Awards and Honors
      The HIP Society - 2011Frank Stinchfield Hip Society Award
      American Orthopaedic Association - 2011ABC Traveling Fellowship
      Orthopaedic Research Society - 2011Marshall R. Urist Award for Excellence in Tissue Regeneration Research
      American Academy of Orthopaedic Surgeons - 2012Elizabeth Winston Lanier Kappa Delta Research Award
      Keck School of Medicine - 2015Outstanding Required Student Project Mentor Award
      Los Angeles Magazine2016Super Doctor
      Castle Connolly2016America's Top Doctors

       ORNG Applications 
       Websites
       Featured Videos
       In The News
       Required Scholarly Project Mentor

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Lieberman JR, Cheng V, Cote MP. Pulmonary Embolism Rates Following Total Hip Arthroplasty With Prophylactic Anticoagulation: Some Pulmonary Emboli Cannot Be Avoided. J Arthroplasty. 2016 Sep 28..
        View in: PubMed
      2. Cohen JR, Bradley AT, Lieberman JR. Preoperative Interventions and Charges Before Total Knee Arthroplasty. J Arthroplasty. 2016 Dec; 31(12):2730-2735.e7..
        View in: PubMed
      3. Sharmin F, McDermott C, Lieberman J, Sanjay A, Khan Y. Dual growth factor delivery from biofunctionalized allografts: Sequential VEGF and BMP-2 release to stimulate allograft remodeling. J Orthop Res. 2016 May 07..
        View in: PubMed
      4. Lieberman JR, Polkowski GG, Della Valle CJ. Practice Management Strategies Among Current Members of the American Association of Hip and Knee Surgeons. J Arthroplasty. 2016 Sep; 31(9 Suppl):3-6..
        View in: PubMed
      5. Lieberman JR. American Association of Hip and Knee Surgeons and Outcome Measures After Total Joint Arthroplasty. J Arthroplasty. 2016 Jun; 31(6):1137-8..
        View in: PubMed
      6. Bohl DD, Maltenfort MG, Huang R, Parvizi J, Lieberman JR, Della Valle CJ. Development and Validation of a Risk Stratification System for Pulmonary Embolism After Elective Primary Total Joint Arthroplasty. J Arthroplasty. 2016 Sep; 31(9 Suppl):187-91..
        View in: PubMed
      7. Teuscher DD, Lieberman JR. A Randomized, Controlled Trial of Total Knee Replacement. N Engl J Med. 2016 Feb 18; 374(7):691-2..
        View in: PubMed
      8. Bougioukli S, Jain A, Sugiyama O, Tinsley BA, Tang AH, Tan MH, Adams DJ, Kostenuik PJ, Lieberman JR. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. Bone. 2015 Dec 23..
        View in: PubMed
      9. Tinsley BA, Dukas A, Pensak MJ, Adams DJ, Tang AH, Ominsky MS, Ke HZ, Lieberman JR. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model. J Bone Joint Surg Am. 2015 Nov 18; 97(22):1852-9..
        View in: PubMed
      10. Lieberman JR. Editorial. J Arthroplasty. 2015 Nov; 30(11):1859..
        View in: PubMed
      11. Meneghini RM, Hull JR, Russo GS, Lieberman JR, Jiranek WA. Porous Tantalum Buttress Augments for Severe Acetabular Posterior Column Deficiency. Surg Technol Int. 2015 Nov; 27:240-4..
        View in: PubMed
      12. Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update. J Bone Joint Surg Am. 2015 Oct 7; 97(19):1604-27..
        View in: PubMed
      13. Pierce TP, Cherian JJ, Jauregui JJ, Elmallah RK, Lieberman JR, Mont MA. A Current Review of Mechanical Compression and Its Role in Venous Thromboembolic Prophylaxis in Total Knee and Total Hip Arthroplasty. J Arthroplasty. 2015 Dec; 30(12):2279-84..
        View in: PubMed
      14. Stavrakis AI, SooHoo NF, Lieberman JR. In Reply to Letter to the Editor "Bilateral Total Hip Arthroplasty has Similar Complication Rates to Unilateral Total Hip Arthroplasty". J Arthroplasty. 2015 Oct; 30(10):1856-7..
        View in: PubMed
      15. Pensak M, Hong SH, Dukas A, Bayron J, Tinsley B, Jain A, Tang A, Rowe D, Lieberman JR. Combination therapy with PTH and DBM cannot heal a critical sized murine femoral defect. J Orthop Res. 2015 Aug; 33(8):1242-9..
        View in: PubMed
      16. Lonner JH, Scuderi GR, Lieberman JR. Potential utility of liposome bupivacaine in orthopedic surgery. Am J Orthop (Belle Mead NJ). 2015 Mar; 44(3):111-7..
        View in: PubMed
      17. Sharmin F, Adams D, Pensak M, Dukas A, Lieberman J, Khan Y. Biofunctionalizing devitalized bone allografts through polymer-mediated short and long term growth factor delivery. J Biomed Mater Res A. 2015 Sep; 103(9):2847-54..
        View in: PubMed
      18. Stavrakis AI, SooHoo NF, Lieberman JR. Bilateral Total Hip Arthroplasty has Similar Complication Rates to Unilateral Total Hip Arthroplasty. J Arthroplasty. 2015 Jul; 30(7):1211-4..
        View in: PubMed
      19. van der Jagt D, Mokete L, Pietrzak J, Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2015 Feb; 23(2):69-70..
        View in: PubMed
      20. Lanting BA, Lieberman JR, Callaghan JJ, Berend ME, MacDonald SJ. Ensuring a Winner: The ABCs of Primary Total Knee Arthroplasty. Instr Course Lect. 2015; 64:369-79..
        View in: PubMed
      21. Alaee F, Bartholomae C, Sugiyama O, Virk MS, Drissi H, Wu Q, Schmidt M, Lieberman JR. Biodistribution of LV-TSTA Transduced Rat Bone Marrow Cells Used for "Ex-vivo" Regional Gene Therapy for Bone Repair. Curr Gene Ther. 2015; 15(5):481-91..
        View in: PubMed
      22. Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014 Jul; 22(7):455-64..
        View in: PubMed
      23. Alaee F, Hong SH, Dukas AG, Pensak MJ, Rowe DW, Lieberman JR. Evaluation of osteogenic cell differentiation in response to bone morphogenetic protein or demineralized bone matrix in a critical sized defect model using GFP reporter mice. J Orthop Res. 2014 Sep; 32(9):1120-8..
        View in: PubMed
      24. Bozic KJ, Grosso LM, Lin Z, Parzynski CS, Suter LG, Krumholz HM, Lieberman JR, Berry DJ, Bucholz R, Han L, Rapp MT, Bernheim S, Drye EE. Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2014 Apr 16; 96(8):640-7..
        View in: PubMed
      25. Van Citters AD, Fahlman C, Goldmann DA, Lieberman JR, Koenig KM, Digioia AM, O'Donnell B, Martin J, Federico FA, Bankowitz RA, Nelson EC, Bozic KJ. Developing a Pathway for High-value, Patient-centered Total Joint Arthroplasty. Clin Orthop Relat Res. 2014 May; 472(5):1619-35..
        View in: PubMed
      26. Alaee F, Virk MS, Tang H, Sugiyama O, Adams DJ, Stolina M, Dwyer D, Ominsky MS, Ke HZ, Lieberman JR. Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model. J Orthop Res. 2014 Feb; 32(2):197-203..
        View in: PubMed
      27. Lieberman JR, Engstrom SM, Solovyova O, Au C, Grady JJ. Is intra-articular hyaluronic acid effective in treating osteoarthritis of the hip joint? J Arthroplasty. 2015 Mar; 30(3):507-11..
        View in: PubMed
      28. Lieberman JR, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013 Oct 2; 95(19):1801-11..
        View in: PubMed
      29. Meneghini RM, Russo GS, Lieberman JR. Modern perceptions and expectations regarding total knee arthroplasty. J Knee Surg. 2014 Apr; 27(2):93-8..
        View in: PubMed
      30. Lieberman JR, Varthi AG, Polkowski GG. Osteonecrosis of the knee - which joint preservation procedures work? J Arthroplasty. 2014 Jan; 29(1):52-6..
        View in: PubMed
      31. Meneghini RM, Daluga AT, Sturgis LA, Lieberman JR. Is the pie-crusting technique safe for MCL release in varus deformity correction in total knee arthroplasty? J Arthroplasty. 2013 Sep; 28(8):1306-9..
        View in: PubMed
      32. Virk MS, Alaee F, Tang H, Ominsky MS, Ke HZ, Lieberman JR. Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model. J Bone Joint Surg Am. 2013 Apr 17; 95(8):694-701..
        View in: PubMed
      33. SooHoo NF, Farng E, Chambers L, Znigmond DS, Lieberman JR. Comparison of complication rates between hemiarthroplasty and total hip arthroplasty for intracapsular hip fractures. Orthopedics. 2013 Apr; 36(4):e384-9..
        View in: PubMed
      34. Lieberman JR, Pensak MJ, Kelleher MS, Leger RR, Polkowski GG. Disclosure of financial conflicts of interest: an evaluation of orthopaedic surgery patients' understanding. Clin Orthop Relat Res. 2013 Feb; 471(2):472-7..
        View in: PubMed
      35. Pensak MJ, Lieberman JR. Gene therapy for bone regeneration. Curr Pharm Des. 2013; 19(19):3466-73..
        View in: PubMed
      36. Virk MS, Lieberman JR. Biologic adjuvants for fracture healing. Arthritis Res Ther. 2012; 14(6):225..
        View in: PubMed
      37. Soung do Y, Talebian L, Matheny CJ, Guzzo R, Speck ME, Lieberman JR, Speck NA, Drissi H. Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing. J Bone Miner Res. 2012 Jul; 27(7):1585-97..
        View in: PubMed
      38. Wisniewski J, Lieberman J, Nowak-Wegrzyn A, Kerkar N, Arnon R, Iyer K, Miloh T. De novo food sensitization and eosinophilic gastrointestinal disease in children post-liver transplantation. Clin Transplant. 2012 Jul-Aug; 26(4):E365-71..
        View in: PubMed
      39. Lieberman JR. American College of Chest Physicians evidence-based guidelines for venous thromboembolic prophylaxis: the guideline wars are over. J Am Acad Orthop Surg. 2012 Jun; 20(6):333-5..
        View in: PubMed
      40. Preventing venous thromboembolic disease in patients undergoing elective total hip and knee arthroplasty. J Bone Joint Surg Am. 2012 Apr 18; 94(8):673-4..
        View in: PubMed
      41. Kapinas K, Lowther KM, Kessler CB, Tilbury K, Lieberman JR, Tirnauer JS, Campagnola P, Delany AM. Bone matrix osteonectin limits prostate cancer cell growth and survival. Matrix Biol. 2012 Jun; 31(5):299-307..
        View in: PubMed
      42. Lieberman JR, Freiberg AA, Lavernia CJ. Practice management strategies among members of the American Association of Hip and Knee Surgeons. J Arthroplasty. 2012 Sep; 27(8 Suppl):17-9.e1-6..
        View in: PubMed
      43. Kimelman Bleich N, Kallai I, Lieberman JR, Schwarz EM, Pelled G, Gazit D. Gene therapy approaches to regenerating bone. Adv Drug Deliv Rev. 2012 Sep; 64(12):1320-30..
        View in: PubMed
      44. Lieberman JR, Engstrom SM, Meneghini RM, SooHoo NF. Which factors influence preservation of the osteonecrotic femoral head? Clin Orthop Relat Res. 2012 Feb; 470(2):525-34..
        View in: PubMed
      45. Dalury DF, Lieberman JR, Macdonald SJ. Current and innovative pain management techniques in total knee arthroplasty. Instr Course Lect. 2012; 61:383-8..
        View in: PubMed
      46. Lieberman JR. The new AAOS clinical practice guidelines on venous thromboembolic prophylaxis: how to adapt them to your practice. J Am Acad Orthop Surg. 2011 Dec; 19(12):717-21..
        View in: PubMed
      47. Lieberman JR. Hybrid and cementless total hip replacements in patients younger than fifty years of age were similar after eighteen years. J Bone Joint Surg Am. 2011 Nov 16; 93(22):2123..
        View in: PubMed
      48. Anderson FA, Huang W, Friedman RJ, Kwong LM, Lieberman JR, Pellegrini VD. Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons. J Arthroplasty. 2012 May; 27(5):659-66.e5..
        View in: PubMed
      49. Dalury DF, Lieberman JR, MacDonald SJ. Current and innovative pain management techniques in total knee arthroplasty. J Bone Joint Surg Am. 2011 Oct 19; 93(20):1938-43..
        View in: PubMed
      50. Lieberman JR, Leger RR, Tao JC, Clohisy JC, Meneghini RM. Total hip arthroplasty surveillance: when do we see our patients postoperatively? J Arthroplasty. 2011 Dec; 26(8):1161-4..
        View in: PubMed
      51. Meneghini RM, Russo GS, Lieberman JR. Research in THA and TKA from the United States has declined over the past decade relative to other countries. Orthopedics. 2011 Jul; 34(7):e245-50..
        View in: PubMed
      52. Alaee F, Sugiyama O, Virk MS, Tang Y, Wang B, Lieberman JR. In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing. Genet Vaccines Ther. 2011; 9:4..
        View in: PubMed
      53. Virk MS, Sugiyama O, Park SH, Gambhir SS, Adams DJ, Drissi H, Lieberman JR. "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair. Mol Ther. 2011 May; 19(5):960-8..
        View in: PubMed
      54. Virk MS, Alaee F, Petrigliano FA, Sugiyama O, Chatziioannou AF, Stout D, Dougall WC, Lieberman JR. Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion. Bone. 2011 Mar 1; 48(3):578-87..
        View in: PubMed
      55. Bernthal NM, Stavrakis AI, Billi F, Cho JS, Kremen TJ, Simon SI, Cheung AL, Finerman GA, Lieberman JR, Adams JS, Miller LS. A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One. 2010; 5(9):e12580..
        View in: PubMed
      56. Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010 Sep; 468(9):2363-71..
        View in: PubMed
      57. Sheth NP, Lieberman JR, Della Valle CJ. DVT prophylaxis in total joint reconstruction. Orthop Clin North Am. 2010 Apr; 41(2):273-80..
        View in: PubMed
      58. Lieberman J. Skin adhesive or staples were not different for skin closure after total hip replacement. J Bone Joint Surg Am. 2010 Feb; 92(2):476..
        View in: PubMed
      59. Petrigliano FA, Virk MS, Liu N, Sugiyama O, Yu D, Lieberman JR. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter. Prostate. 2009 Sep 15; 69(13):1422-34..
        View in: PubMed
      60. Lieberman JR, Barnes CL, Lachiewicz PF, Hanssen AD, Clarke HD, Pellegrini VD. Venous thromboembolism debate in joint arthroplasty. J Bone Joint Surg Am. 2009 Aug; 91 Suppl 5:29-32..
        View in: PubMed
      61. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P, Haralson RH, Watters WC. American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am. 2009 Jul; 91(7):1756-7..
        View in: PubMed
      62. Cuomo AV, Virk M, Petrigliano F, Morgan EF, Lieberman JR. Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside. J Bone Joint Surg Am. 2009 May; 91(5):1073-83..
        View in: PubMed
      63. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P, Haralson RH, Watters WC. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009 Mar; 17(3):183-96..
        View in: PubMed
      64. Lieberman JR. Medial-wedge insoles improved pain and function in osteoarthritic knees with valgus deformity. J Bone Joint Surg Am. 2009 Feb; 91(2):493..
        View in: PubMed
      65. Lieberman JR. Two alternative bearings for total hip arthroplasty: more data are needed. J Am Acad Orthop Surg. 2009 Feb; 17(2):61-2..
        View in: PubMed
      66. Soohoo NF, Lieberman JR, Farng E, Park S, Jain S, Ko CY. Perioperative quality-of-care measures for patients undergoing total hip or total knee replacement. J Long Term Eff Med Implants. 2009; 19(4):249-53..
        View in: PubMed
      67. Virk MS, Petrigliano FA, Liu NQ, Chatziioannou AF, Stout D, Kang CO, Dougall WC, Lieberman JR. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. Bone. 2009 Jan; 44(1):160-7..
        View in: PubMed
      68. Pianta TJ, Lieberman JR. Cement retention in revision total hip arthroplasty: filling the hole. Orthopedics. 2008 Sep; 31(9):909-10..
        View in: PubMed
      69. Miyazaki M, Sugiyama O, Tow B, Zou J, Morishita Y, Wei F, Napoli A, Sintuu C, Lieberman JR, Wang JC. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Spinal Disord Tech. 2008 Jul; 21(5):372-9..
        View in: PubMed
      70. Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008 Jun 26; 358(26):2776-86..
        View in: PubMed
      71. Miyazaki M, Sugiyama O, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Virk MS, Lieberman JR, Wang JC. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine (Phila Pa 1976). 2008 Jun 1; 33(13):1410-7..
        View in: PubMed
      72. Hsu WK, Wang JC, Liu NQ, Krenek L, Zuk PA, Hedrick MH, Benhaim P, Lieberman JR. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am. 2008 May; 90(5):1043-52..
        View in: PubMed
      73. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9..
        View in: PubMed
      74. Hsu WK, Virk MS, Feeley BT, Stout DB, Chatziioannou AF, Lieberman JR. Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT. J Nucl Med. 2008 Mar; 49(3):414-21..
        View in: PubMed
      75. Carofino BC, Lieberman JR. Gene therapy applications for fracture-healing. J Bone Joint Surg Am. 2008 Feb; 90 Suppl 1:99-110..
        View in: PubMed
      76. Virk MS, Conduah A, Park SH, Liu N, Sugiyama O, Cuomo A, Kang C, Lieberman JR. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone. 2008 May; 42(5):921-31..
        View in: PubMed
      77. Lieberman JR, Roth KM, Elsissy P, Dorey FJ, Kobashigawa JA. Symptomatic osteonecrosis of the hip and knee after cardiac transplantation. J Arthroplasty. 2008 Jan; 23(1):90-6..
        View in: PubMed
      78. Soohoo NF, Vyas RM, Samimi DB, Molina R, Lieberman JR. Comparison of the responsiveness of the SF-36 and WOMAC in patients undergoing total hip arthroplasty. J Arthroplasty. 2007 Dec; 22(8):1168-73..
        View in: PubMed
      79. Petrigliano FA, Lieberman JR. Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res. 2007 Dec; 465:53-62..
        View in: PubMed
      80. Pariente N, Morizono K, Virk MS, Petrigliano FA, Reiter RE, Lieberman JR, Chen IS. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther. 2007 Nov; 15(11):1973-81..
        View in: PubMed
      81. Richardson JA, Amantea CM, Kianmahd B, Tetradis S, Lieberman JR, Hahn TJ, Parhami F. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway. J Cell Biochem. 2007 Apr 1; 100(5):1131-45..
        View in: PubMed
      82. Wang JC, Alanay A, Mark D, Kanim LE, Campbell PA, Dawson EG, Lieberman JR. A comparison of commercially available demineralized bone matrix for spinal fusion. Eur Spine J. 2007 Aug; 16(8):1233-40..
        View in: PubMed
      83. Virk MS, Lieberman JR. Tumor metastasis to bone. Arthritis Res Ther. 2007; 9 Suppl 1:S5..
        View in: PubMed
      84. Feeley BT, Liu NQ, Conduah AH, Krenek L, Roth K, Dougall WC, Huard J, Dubinett S, Lieberman JR. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res. 2006 Oct; 21(10):1571-80..
        View in: PubMed
      85. Soohoo NF, Sharifi H, Kominski G, Lieberman JR. Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. J Bone Joint Surg Am. 2006 Sep; 88(9):1975-82..
        View in: PubMed
      86. Gamradt SC, Abe N, Bahamonde ME, Lee YP, Nelson SD, Lyons KM, Lieberman JR. Tracking expression of virally mediated BMP-2 in gene therapy for bone repair. Clin Orthop Relat Res. 2006 Sep; 450:238-45..
        View in: PubMed
      87. Feeley BT, Conduah AH, Sugiyama O, Krenek L, Chen IS, Lieberman JR. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. J Orthop Res. 2006 Aug; 24(8):1709-21..
        View in: PubMed
      88. Soohoo NF, Vyas S, Manunga J, Sharifi H, Kominski G, Lieberman JR. Cost-effectiveness analysis of core decompression. J Arthroplasty. 2006 Aug; 21(5):670-81..
        View in: PubMed
      89. Soohoo NF, Zingmond DS, Lieberman JR, Ko CY. Optimal timeframe for reporting short-term complication rates after total knee arthroplasty. J Arthroplasty. 2006 Aug; 21(5):705-11..
        View in: PubMed
      90. SooHoo NF, Lieberman JR, Ko CY, Zingmond DS. Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am. 2006 Mar; 88(3):480-5..
        View in: PubMed
      91. Soohoo NF, Zingmond DS, Lieberman JR, Ko CY. Primary total knee arthroplasty in California 1991 to 2001: does hospital volume affect outcomes? J Arthroplasty. 2006 Feb; 21(2):199-205..
        View in: PubMed
      92. Lieberman JR, Romano PS, Mahendra G, Keyzer J, Chilcott M. The treatment of hip fractures: variations in care. Clin Orthop Relat Res. 2006 Jan; 442:239-44..
        View in: PubMed
      93. Conduah A, Lieberman JR. Venous thromboembolic prophylaxis after elective total hip arthroplasty. Clin Orthop Relat Res. 2005 Dec; 441:274-84..
        View in: PubMed
      94. Lee YP, Jo M, Luna M, Chien B, Lieberman JR, Wang JC. The efficacy of different commercially available demineralized bone matrix substances in an athymic rat model. J Spinal Disord Tech. 2005 Oct; 18(5):439-44..
        View in: PubMed
      95. Colwell CW, Berkowitz SD, Lieberman JR, Comp PC, Ginsberg JS, Paiement G, McElhattan J, Roth AW, Francis CW. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2005 Oct; 87(10):2169-77..
        View in: PubMed
      96. Lieberman JR, Hsu WK. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2005 Sep; 87(9):2097-112..
        View in: PubMed
      97. Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone. 2006 Feb; 38(2):154-66..
        View in: PubMed
      98. Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, Rubery PT, Schwarz EM, O'Keefe RJ, Guldberg RE. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res. 2005 Dec; 20(12):2124-37..
        View in: PubMed
      99. Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res. 2005 Dec; 20(12):2189-99..
        View in: PubMed
      100. Whang PG, Schwarz EM, Gamradt SC, Dougall WC, Lieberman JR. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone. J Orthop Res. 2005 Nov; 23(6):1475-83..
        View in: PubMed
      101. Lieberman JR. Cemented femoral revision: lest we forget. J Arthroplasty. 2005 Jun; 20(4 Suppl 2):72-4..
        View in: PubMed
      102. Dragoo JL, Lieberman JR, Lee RS, Deugarte DA, Lee Y, Zuk PA, Hedrick MH, Benhaim P. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg. 2005 May; 115(6):1665-73..
        View in: PubMed
      103. Callaghan JJ, Crowninshield RD, Greenwald AS, Lieberman JR, Rosenberg AG, Lewallen DG. Symposium: introducing technology into orthopaedic practice. How should it be done? J Bone Joint Surg Am. 2005 May; 87(5):1146-58..
        View in: PubMed
      104. Sugiyama O, An DS, Kung SP, Feeley BT, Gamradt S, Liu NQ, Chen IS, Lieberman JR. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther. 2005 Mar; 11(3):390-8..
        View in: PubMed
      105. Peterson B, Iglesias R, Zhang J, Wang JC, Lieberman JR. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine (Phila Pa 1976). 2005 Feb 1; 30(3):283-9; discussion 289-90..
        View in: PubMed
      106. Peterson B, Zhang J, Iglesias R, Kabo M, Hedrick M, Benhaim P, Lieberman JR. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng. 2005 Jan-Feb; 11(1-2):120-9..
        View in: PubMed
      107. Gamradt SC, Feeley BT, Liu NQ, Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman JR. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone. Anticancer Res. 2005 Jan-Feb; 25(1A):107-15..
        View in: PubMed
      108. Sugiyama O, Sung An D, Kung SP, Feeley BT, Gamradt S, Liu NQ, Chen IS, Lieberman JR. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther. 2005 Mar; 11(3):390-398..
        View in: PubMed
      109. Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res. 2004 Dec; (429):139-45..
        View in: PubMed
      110. Lieberman JR, Wenger N. New technology and the orthopaedic surgeon: are you protecting your patients? Clin Orthop Relat Res. 2004 Dec; (429):338-41..
        View in: PubMed
      111. Peterson B, Whang PG, Iglesias R, Wang JC, Lieberman JR. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am. 2004 Oct; 86-A(10):2243-50..
        View in: PubMed
      112. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res. 2004 Dec; 19(12):2021-32..
        View in: PubMed
      113. Kelly MA, Moskowitz RW, Lieberman JR. Hyaluronan therapy: looking toward the future. Am J Orthop (Belle Mead NJ). 2004 Feb; 33(2 Suppl):23-8..
        View in: PubMed
      114. Vangsness CT, Kurzweil PR, Lieberman JR. Restoring articular cartilage in the knee. Am J Orthop (Belle Mead NJ). 2004 Feb; 33(2 Suppl):29-34..
        View in: PubMed
      115. Kelly MA, Kurzweil PR, Lewallen DG, Lieberman JR, Moskowitz RW, Vangsness CT. New therapeutic options for managing the arthritic knee. Am J Orthop (Belle Mead NJ). 2004 Feb; 33(2 Suppl):35-9..
        View in: PubMed
      116. Lieberman JR. Core decompression for osteonecrosis of the hip. Clin Orthop Relat Res. 2004 Jan; (418):29-33..
        View in: PubMed
      117. Gamradt SC, Lieberman JR. Genetic modification of stem cells to enhance bone repair. Ann Biomed Eng. 2004 Jan; 32(1):136-47..
        View in: PubMed
      118. Gamradt SC, Lieberman JR. Bone graft for revision hip arthroplasty: biology and future applications. Clin Orthop Relat Res. 2003 Dec; (417):183-94..
        View in: PubMed
      119. Berry DJ, Berger RA, Callaghan JJ, Dorr LD, Duwelius PJ, Hartzband MA, Lieberman JR, Mears DC. Minimally invasive total hip arthroplasty. Development, early results, and a critical analysis. Presented at the Annual Meeting of the American Orthopaedic Association, Charleston, South Carolina, USA, June 14, 2003. J Bone Joint Surg Am. 2003 Nov; 85-A(11):2235-46..
        View in: PubMed
      120. Lieberman JR. A closed-suction drain was not beneficial in knee arthroplasty with cement. J Bone Joint Surg Am. 2003 Nov; 85-A(11):2257..
        View in: PubMed
      121. Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12..
        View in: PubMed
      122. Kofron MD, Zhang JX, Lieberman JR, Laurencin CT. Genetically modified mesodermal-derived cells for bone tissue engineering. IEEE Eng Med Biol Mag. 2003 Sep-Oct; 22(5):57-64..
        View in: PubMed
      123. Oakes DA, Lee CC, Lieberman JR. An evaluation of human demineralized bone matrices in a rat femoral defect model. Clin Orthop Relat Res. 2003 Aug; (413):281-90..
        View in: PubMed
      124. Dragoo JL, Choi JY, Lieberman JR, Huang J, Zuk PA, Zhang J, Hedrick MH, Benhaim P. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res. 2003 Jul; 21(4):622-9..
        View in: PubMed
      125. Davies MR, Lee YP, Lee C, Zhang X, Afar DE, Lieberman JR. Use of a SCID mouse model to select for a more aggressive strain of prostate cancer. Anticancer Res. 2003 May-Jun; 23(3B):2245-52..
        View in: PubMed
      126. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman JR. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am. 2003 May; 85-A(5):905-11..
        View in: PubMed
      127. Oakes DA, Jackson KR, Davies MR, Ehrhart KM, Zohman GL, Koval KJ, Lieberman JR. The impact of the garden classification on proposed operative treatment. Clin Orthop Relat Res. 2003 Apr; (409):232-40..
        View in: PubMed
      128. Lieberman JR, Thomas BJ, Finerman GA, Dorey F. Patients' reasons for undergoing total hip arthroplasty can change over time. J Arthroplasty. 2003 Jan; 18(1):63-8..
        View in: PubMed
      129. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003; 52:337-55..
        View in: PubMed
      130. Hannallah D, Peterson B, Lieberman JR, Fu FH, Huard J. Gene therapy in orthopaedic surgery. Instr Course Lect. 2003; 52:753-68..
        View in: PubMed
      131. Park SH, Silva M, Bahk WJ, McKellop H, Lieberman JR. Effect of repeated irrigation and debridement on fracture healing in an animal model. J Orthop Res. 2002 Nov; 20(6):1197-204..
        View in: PubMed
      132. Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. Ann Intern Med. 2002 Oct 15; 137(8):648-55..
        View in: PubMed
      133. Lee YP, Schwarz EM, Davies M, Jo M, Gates J, Zhang X, Wu J, Lieberman JR. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. Cancer Res. 2002 Oct 1; 62(19):5564-70..
        View in: PubMed
      134. Abe N, Lee YP, Sato M, Zhang X, Wu J, Mitani K, Lieberman JR. Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2. Biochem Biophys Res Commun. 2002 Sep 27; 297(3):523-7..
        View in: PubMed
      135. Whang PG, Lieberman JR. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2002 Sep; 31(9 Suppl):31-6..
        View in: PubMed
      136. Whang PG, Lieberman JR. Low-molecular-weight herapin. J Am Acad Orthop Surg. 2002 Sep-Oct; 10(5):299-302..
        View in: PubMed
      137. Berger F, Lee YP, Loening AM, Chatziioannou A, Freedland SJ, Leahy R, Lieberman JR, Belldegrun AS, Sawyers CL, Gambhir SS. Whole-body skeletal imaging in mice utilizing microPET: optimization of reproducibility and applications in animal models of bone disease. Eur J Nucl Med Mol Imaging. 2002 Sep; 29(9):1225-36..
        View in: PubMed
      138. Lieberman JR, Ghivizzani SC, Evans CH. Gene transfer approaches to the healing of bone and cartilage. Mol Ther. 2002 Aug; 6(2):141-7..
        View in: PubMed
      139. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002 Jun; 84-A(6):1032-44..
        View in: PubMed
      140. Puzas JE, O'Keefe RJ, Lieberman JR. The orthopaedic genome: what does the future hold and are we ready? J Bone Joint Surg Am. 2002 Jan; 84-A(1):133-41..
        View in: PubMed
      Back to TOP